Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership2,289 shares
Latest Disclosed Value $ 138,828
Pinnacle Bancorp, Inc. ownership in BRM / Bristol-Myers Squibb Company

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 2,289 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $119,989 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 2,289 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $108,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Bristol Myers Squibb Co Com COM 110122108 2,289 0 0.00 139 12.20 0.0410
2026-01-22 2025-12-31 13F Bristol Myers Squibb Co Com COM 110122108 2,289 -500 -17.93 123 -1.60 0.0362
2025-10-24 2025-09-30 13F Bristol Myers Squibb Co Com COM 110122108 2,789 0 0.00 126 -3.10 0.0372
2025-07-11 2025-06-30 13F Bristol Myers Squibb Co Com COM 110122108 2,789 -100 -3.46 129 -26.70 0.0398
2025-04-23 2025-03-31 13F Bristol Myers Squibb Co Com COM 110122108 2,889 -287 -9.04 176 -1.68 0.0574
2025-01-14 2024-12-31 13F Bristol Myers Squibb Co Com COM 110122108 3,176 600 23.29 180 34.59 0.0584
2024-10-09 2024-09-30 13F Bristol Myers Squibb Co Com COM 110122108 2,576 0 0.00 133 25.47 0.0356
2024-07-15 2024-06-30 13F Bristol Myers Squibb Co Com COM 110122108 2,576 -750 -22.55 107 -41.11 0.0316
2024-04-16 2024-03-31 13F Bristol Myers Squibb Co Com COM 110122108 3,326 565 20.46 180 27.66 0.0533
2024-01-25 2023-12-31 13F Bristol Myers Squibb Co Com COM 110122108 2,761 247 9.82 142 -2.76 0.0464
2023-10-18 2023-09-30 13F Bristol Myers Squibb Co Com COM 110122108 2,514 -950 -27.42 146 -34.39 0.0519
2023-07-14 2023-06-30 13F Bristol Myers Squibb Co Com COM 110122108 3,464 100 2.97 222 -5.15 0.0757
2023-04-14 2023-03-31 13F Bristol Myers Squibb Co Com COM 110122108 3,364 0 0.00 233 0.0856
2023-01-24 2022-12-31 13F Bristol Myers Squibb Co Com COM 110122108 3,364 55 1.66 0 -100.00 0.0931
2022-10-25 2022-09-30 13F Bristol Myers Squibb Co Com COM 110122108 3,309 -102 -2.99 235 -10.65 0.1015
2022-07-12 2022-06-30 13F Bristol Myers Squibb Co Com COM 110122108 3,411 1,429 72.10 263 81.38 0.1082
2022-04-14 2022-03-31 13F Bristol Myers Squibb Co Com COM 110122108 1,982 146 7.95 145 27.19 0.0503
2022-01-19 2021-12-31 13F Bristol Myers Squibb Co Com COM 110122108 1,836 0 0.00 114 4.59 0.0403
2021-10-12 2021-09-30 13F Bristol Myers Squibb Co Com COM 110122108 1,836 174 10.47 109 -1.80 0.0436
2021-07-15 2021-06-30 13F Bristol Myers Squibb Co Com COM 110122108 1,662 -219 -11.64 111 -6.72 0.0506
2021-04-26 2021-03-31 13F Bristol Myers Squibb Co Com COM 110122108 1,881 -45 -2.34 119 0.00 0.0577
2021-01-13 2020-12-31 13F Bristol Myers Squibb Co Com COM 110122108 1,926 0 0.00 119 2.59 0.0733
2020-10-13 2020-09-30 13F Bristol Myers Squibb Co Com COM 110122108 1,926 -185 -8.76 116 -6.45 0.0818
2020-07-07 2020-06-30 13F Bristol Myers Squibb Co Com COM 110122108 2,111 0 0.00 124 5.08 0.0922
2020-04-09 2020-03-31 13F Bristol Myers Squibb Co Com COM 110122108 2,111 0 0.00 118 -13.24 0.1008
2020-01-10 2019-12-31 13F Bristol Myers Squibb Co Com COM 110122108 2,111 625 42.06 136 81.33 0.0942
2019-10-08 2019-09-30 13F Bristol Myers Squibb Co Com COM 110122108 1,486 -522 -26.00 75 -17.58 0.0428
2019-07-08 2019-06-30 13F Bristol Myers Squibb Co Com COM 110122108 2,008 -100 -4.74 91 -9.90 0.0511
2019-04-05 2019-03-31 13F Bristol Myers Squibb Co Com COM 110122108 2,108 -609 -22.41 101 -28.37 0.0586
2019-03-20 2018-12-31 13F Bristol Myers Squibb Co Com COM 110122108 2,717 -1,977 -42.12 141 -44.71 0.0867
2017-04-17 2017-03-31 13F Bristol Myers Squibb Co Com COM 110122108 4,694 4,694 255 0.1803
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.